COMPLETED

Diet and Depression

Talk to us

Conditions

DepressionMajor Depressive DisorderWeight GainObesityMetabolic SyndromeUltra-processed FoodDiet

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is a pilot open label crossover trial to assess the feasibility and acceptability of reducing ultra- processed foods (UPF) in a personalized manner from the diets of patients with major depressive disorder who eat a large percentage of UPF.

Official Title

Assessing the Feasibility and Acceptability of the Reduction of Ultra-processed Foods From the Diets of a Subset of Patients With Depression - A Pilot Open Label Crossover Trial.

Quick Facts

Study Start:2024-06-18
Study Completion:2025-06-18
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06252701

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18-80 year olds (inclusive), all race/ethnic groups
  2. * Willing to not change psychotropic medication or psychotherapy regimen during the study
  3. * Willing and able to come to UCSF for in person visits two times
  4. * Ability to speak and read English and answer participant surveys
  1. * Psychiatric hospitalization in past 3 months
  2. * Active suicidal ideation with intent and plan or scoring a 3 or higher on the Columbia suicide severity rating scale (C-SSRS)
  3. * In a current severe mood state when entering the study that would prohibit compliance with study visits or dietary program
  4. * Known GI abnormalities or known GI medical problems (diarrhea, chronic intestinal disease, toxic megacolon, ileum) or known swallowing or chewing disorders or issues
  5. * Anticipating or planning any major changes in physical activity or sleep during the study
  6. * Pregnant or planning to be pregnant during the study
  7. * Breastfeeding or planning to breastfeed during the study

Contacts and Locations

Principal Investigator

D. Nyasha Chagwedera, MD, PhD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Andrew Krystal, MD, MS
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

University of California, San Francisco
San Francisco, California, 94107
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • D. Nyasha Chagwedera, MD, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco
  • Andrew Krystal, MD, MS, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-18
Study Completion Date2025-06-18

Study Record Updates

Study Start Date2024-06-18
Study Completion Date2025-06-18

Terms related to this study

Keywords Provided by Researchers

  • Ultra-processed Food
  • Depression
  • Diet

Additional Relevant MeSH Terms

  • Depression
  • Major Depressive Disorder
  • Weight Gain
  • Obesity
  • Metabolic Syndrome